Japanese 2011 guidelines for prevention and treatment of osteoporosis—executive summaryHajime Orimo, Saeko Fujiwara, Takayuki Hosoi et al.|Archives of Osteoporosis|2012Cited by 360
The JNK pathway represents a novel target in the treatment of rheumatoid arthritis through the suppression of MMP-3Tomotake Kanai, Naoto Endo|Journal of Orthopaedic Surgery and Research|2020Cited by 37
Effect of temozolomide on the viability of musculoskeletal sarcoma cellsYuta Kusabe, Naoto Endo|Oncology Letters|2015Cited by 6